Safety and Pharmacokinetics of SANGUINATE™ in Sickle Cell Disease (SCD) Patients

Clinical trial NCT01374165 · WITHDRAWN

Trial details

NCT number: NCT01374165
Sponsor: Prolong Pharmaceuticals
Status: WITHDRAWN
Study type: OBSERVATIONAL

Sickle Cell Disease

Start date: 2015-01-01
Primary completion: 2015-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.